Authors |
|
xi | |
Preface and Acknowledgements |
|
xvii | |
|
Section I Comprehensive Evaluation and Treatment |
|
|
73 | (406) |
|
|
1 | (3) |
|
|
4 | (4) |
|
|
4 | (1) |
|
|
5 | (2) |
|
|
7 | (1) |
|
|
8 | (11) |
|
Bradycardia and Atrioventricular Block |
|
|
8 | (1) |
|
QRS Interval Prolongation |
|
|
9 | (3) |
|
|
12 | (1) |
|
|
13 | (2) |
|
|
15 | (2) |
|
|
17 | (2) |
|
|
19 | (7) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
21 | (2) |
|
|
23 | (2) |
|
Agitation, Delirium, or Psychosis |
|
|
25 | (1) |
|
|
26 | (4) |
|
Dystonia, Dyskinesia, and Rigidity |
|
|
26 | (2) |
|
|
28 | (1) |
|
Anaphylactic and Anaphylactoid Reactions |
|
|
29 | (1) |
|
|
30 | (21) |
|
|
30 | (1) |
|
|
30 | (4) |
|
Essential Clinical Laboratory Tests |
|
|
34 | (1) |
|
Serum Osmolality and Osmol gap |
|
|
34 | (2) |
|
Anion Gap Metabolic Acidosis |
|
|
36 | (1) |
|
Hyperglycemia and Hypoglycemia |
|
|
37 | (1) |
|
Hypernatremia and Hyponatremia |
|
|
38 | (3) |
|
Hyperkalemia and Hypokalemia |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
44 | (6) |
|
|
50 | (1) |
|
|
51 | (5) |
|
|
51 | (1) |
|
Decontamination of the Eyes |
|
|
51 | (1) |
|
Decontamination after Inhalation |
|
|
52 | (1) |
|
Gastrointestinal Decontamination |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
56 | (4) |
|
|
59 | (1) |
|
|
59 | (1) |
|
|
59 | (1) |
|
|
59 | (1) |
|
Continuous Renal Replacement Therapy |
|
|
59 | (1) |
|
Repeat-dose Activated Charcoal |
|
|
59 | (1) |
|
Disposition of the Patient |
|
|
60 | (2) |
|
Special Considerations in Pediatric Patients |
|
|
62 | (3) |
|
Pregnancy and Breastfeeding |
|
|
65 | (5) |
|
Forensic Issues/Postmortem Toxicology |
|
|
70 | (1) |
|
Evaluation of Drug-Facilitated Crimes |
|
|
71 | (408) |
|
Section II Specific Poisons and Drugs: Diagnosis and Treatment |
|
|
479 | (118) |
|
|
74 | (4) |
|
Aconite and Other Sodium Channel Openers |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
80 | (2) |
|
|
82 | (4) |
|
|
86 | (2) |
|
Angiotensin Blockers and ACE Inhibitors |
|
|
88 | (2) |
|
|
90 | (3) |
|
|
93 | (5) |
|
|
98 | (1) |
|
Anticoagulants, Direct Oral |
|
|
99 | (3) |
|
|
102 | (2) |
|
Antidepressants, General (Noncyclic) |
|
|
104 | (3) |
|
Antidepressants, Tricyclic |
|
|
107 | (3) |
|
|
110 | (3) |
|
|
113 | (2) |
|
|
115 | (15) |
|
|
130 | (2) |
|
Antiseptics and Disinfectants |
|
|
132 | (2) |
|
Antiviral and Antiretroviral Agents |
|
|
134 | (4) |
|
|
138 | (4) |
|
|
142 | (3) |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
147 | (2) |
|
|
149 | (2) |
|
|
151 | (2) |
|
|
153 | (2) |
|
|
155 | (2) |
|
Beta2-adrenergic Stimulants |
|
|
157 | (2) |
|
Boric acid, Borates, and Boron |
|
|
159 | (1) |
|
|
160 | (3) |
|
|
163 | (1) |
|
|
164 | (1) |
|
|
165 | (2) |
|
|
167 | (2) |
|
Calcium Channel Antagonists |
|
|
169 | (3) |
|
Camphor and Other Essential Oils |
|
|
172 | (2) |
|
Carbamazepine and Oxcarbazepine |
|
|
174 | (3) |
|
|
177 | (1) |
|
|
178 | (3) |
|
Carbon Tetrachloride and Chloroform |
|
|
181 | (1) |
|
Caustic and Corrosive Agents |
|
|
182 | (3) |
|
|
185 | (1) |
|
Chlorinated Hydrocarbon Pesticides |
|
|
186 | (1) |
|
|
187 | (2) |
|
Chlorophenoxy Herbicides (2,4-D) |
|
|
189 | (1) |
|
Chloroquine and Other Aminoquinolines |
|
|
190 | (2) |
|
|
192 | (2) |
|
Clonidine and Related Drugs |
|
|
194 | (2) |
|
|
196 | (2) |
|
|
198 | (3) |
|
|
201 | (2) |
|
|
203 | (2) |
|
|
205 | (2) |
|
|
207 | (3) |
|
|
210 | (2) |
|
|
212 | (2) |
|
|
214 | (4) |
|
Digoxin and Other Cardiac Glycosides |
|
|
218 | (3) |
|
|
221 | (1) |
|
|
222 | (2) |
|
|
224 | (2) |
|
|
226 | (2) |
|
|
228 | (3) |
|
Ethylene Glycol and Other Glycols |
|
|
231 | (4) |
|
|
235 | (1) |
|
|
236 | (2) |
|
|
238 | (2) |
|
Food Poisoning: Bacterial |
|
|
240 | (2) |
|
Food Poisoning: Fish and Shellfish |
|
|
242 | (4) |
|
|
246 | (1) |
|
|
247 | (2) |
|
Gamma-hydroxybutyrate (GHB) |
|
|
249 | (2) |
|
|
251 | (2) |
|
|
253 | (2) |
|
|
255 | (2) |
|
Herbal and Alternative Products |
|
|
257 | (6) |
|
|
263 | (3) |
|
Hydrogen Fluoride and Hydrofluoric Acid |
|
|
266 | (3) |
|
|
269 | (1) |
|
|
270 | (1) |
|
|
271 | (2) |
|
|
273 | (2) |
|
|
275 | (1) |
|
|
276 | (2) |
|
|
278 | (2) |
|
Jellyfish and Other Cnidaria |
|
|
280 | (2) |
|
|
282 | (5) |
|
Lionfish and Other Scorpaenidae |
|
|
287 | (2) |
|
|
289 | (2) |
|
Lomotil and Other Antidiarrheals |
|
|
291 | (2) |
|
Lysergic Acid Diethylamide (LSD) and Other Hallucinogens |
|
|
293 | (4) |
|
|
297 | (2) |
|
|
299 | (1) |
|
Marijuana and Cannabinoids |
|
|
300 | (3) |
|
|
303 | (5) |
|
|
308 | (1) |
|
|
309 | (1) |
|
|
310 | (2) |
|
|
312 | (2) |
|
|
314 | (2) |
|
|
316 | (2) |
|
|
318 | (2) |
|
|
320 | (2) |
|
|
322 | (2) |
|
Monoamine Oxidase Inhibitors |
|
|
324 | (3) |
|
|
327 | (3) |
|
|
330 | (2) |
|
Naphthalene and Paradichlorobenzene |
|
|
332 | (2) |
|
|
334 | (2) |
|
|
336 | (2) |
|
|
338 | (1) |
|
|
339 | (1) |
|
|
340 | (2) |
|
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
|
|
342 | (2) |
|
Nontoxic or Minimally Toxic Household Products |
|
|
344 | (2) |
|
|
346 | (3) |
|
Organophosphorus and Carbamate Insecticides |
|
|
349 | (9) |
|
|
358 | (1) |
|
|
359 | (2) |
|
Pentachlorophenol and Dinitrophenol |
|
|
361 | (1) |
|
Phencyclidine (PCP) and Ketamine |
|
|
362 | (3) |
|
Phenol and Related Compounds |
|
|
365 | (1) |
|
|
366 | (2) |
|
|
368 | (1) |
|
|
369 | (2) |
|
|
371 | (1) |
|
|
372 | (19) |
|
Polychlorinated Biphenyls (PCBs) |
|
|
391 | (2) |
|
Pseudoephedrine, Phenylephrine, and Other Decongestants |
|
|
393 | (2) |
|
Pyrethrins and Pyrethroids |
|
|
395 | (2) |
|
Quinidine and Other Type la Antiarrhythmic Drugs |
|
|
397 | (1) |
|
|
398 | (2) |
|
|
400 | (4) |
|
Rodenticides, Miscellaneous |
|
|
404 | (5) |
|
|
409 | (2) |
|
|
411 | (2) |
|
|
413 | (2) |
|
|
415 | (2) |
|
Skeletal Muscle Relaxants |
|
|
417 | (2) |
|
|
419 | (2) |
|
|
421 | (4) |
|
|
425 | (3) |
|
|
428 | (1) |
|
|
429 | (1) |
|
|
430 | (2) |
|
|
432 | (1) |
|
|
433 | (2) |
|
|
435 | (1) |
|
|
436 | (2) |
|
Trichloroethane, Trichloroethylene, and Tetrachloroethylene |
|
|
438 | (2) |
|
|
440 | (3) |
|
|
443 | (1) |
|
|
444 | (2) |
|
Warfare Agents - Biological |
|
|
446 | (5) |
|
Warfare Agents - Chemical |
|
|
451 | (7) |
|
Warfarin and Superwarfarins |
|
|
458 | (3) |
|
|
461 | (136) |
|
Section III Therapeutic Drugs and Antidotes |
|
|
597 | (124) |
|
|
481 | (3) |
|
|
484 | (2) |
|
Antipsychotic Drugs (Haloperidol, Droperidol, Olanzapine, and Ziprasidone) |
|
|
486 | (2) |
|
Antivenom, Centruroides (Scorpion) |
|
|
488 | (1) |
|
Antivenom, Crotalidae (Rattlesnake) |
|
|
489 | (2) |
|
Antivenom, Latrodectus Mactans (Black Widow Spider) |
|
|
491 | (1) |
|
Antivenom, Micrurus Fulvius (Coral Snake) and Exotic Antivenoms |
|
|
492 | (2) |
|
Atropine and Glycopyrrolate |
|
|
494 | (1) |
|
|
495 | (2) |
|
Benzodiazepines (Diazepam, Lorazepam, and Midazolam) |
|
|
497 | (3) |
|
|
500 | (1) |
|
|
501 | (2) |
|
|
503 | (1) |
|
|
504 | (2) |
|
|
506 | (2) |
|
Carnitine (Levocarnitine) |
|
|
508 | (1) |
|
|
509 | (2) |
|
Cimetidine and Other H2 Blockers |
|
|
511 | (1) |
|
Clotting Factor Replacement Products |
|
|
512 | (3) |
|
|
515 | (1) |
|
|
515 | (2) |
|
|
517 | (1) |
|
|
518 | (1) |
|
Digoxin-Specific Antibodies |
|
|
519 | (2) |
|
|
521 | (1) |
|
|
522 | (2) |
|
DTPA (Diethylenetriaminepentaacetate) |
|
|
524 | (1) |
|
EDTA, Calcium (Calcium Disodium Edetate, Calcium Disodium Versenate) |
|
|
525 | (2) |
|
|
527 | (2) |
|
|
529 | (1) |
|
|
530 | (2) |
|
|
532 | (1) |
|
|
533 | (1) |
|
Fomepizole (4-Methylpyrazole, 4-MP) |
|
|
534 | (2) |
|
|
536 | (1) |
|
|
537 | (1) |
|
|
538 | (1) |
|
|
539 | (1) |
|
|
540 | (1) |
|
|
541 | (1) |
|
Iodide (Potassium Iodide, Kl) |
|
|
542 | (2) |
|
|
544 | (1) |
|
|
545 | (2) |
|
|
547 | (1) |
|
|
548 | (1) |
|
|
549 | (1) |
|
|
550 | (2) |
|
|
552 | (1) |
|
|
553 | (1) |
|
|
554 | (1) |
|
|
555 | (2) |
|
|
557 | (2) |
|
|
559 | (4) |
|
|
563 | (1) |
|
|
564 | (1) |
|
|
565 | (2) |
|
|
567 | (1) |
|
|
568 | (1) |
|
Oxygen and Hyperbaric Oxygen |
|
|
569 | (2) |
|
|
571 | (1) |
|
|
572 | (1) |
|
|
573 | (2) |
|
|
575 | (1) |
|
|
575 | (1) |
|
Physostigmine and Neostigmine |
|
|
576 | (2) |
|
|
578 | (1) |
|
Pralidoxime (2-PAM) and Other Oximes |
|
|
579 | (2) |
|
|
581 | (2) |
|
|
583 | (2) |
|
|
585 | (1) |
|
|
586 | (1) |
|
|
587 | (1) |
|
|
588 | (1) |
|
|
589 | (2) |
|
|
591 | (1) |
|
|
592 | (1) |
|
|
593 | (2) |
|
|
595 | (1) |
|
Vitamin K, (Phytonadione) |
|
|
596 | (125) |
|
Section IV Environmental and Occupational Toxicology |
|
|
721 | (2) |
|
Emergency Medical Response to Hazardous Materials Incidents |
|
|
598 | (8) |
|
Evaluation of the Patient with Occupational Chemical Exposure |
|
|
606 | (9) |
|
The Toxic Hazards of Industrial and Occupational Chemicals |
|
|
615 | (6) |
|
Health Hazard Summaries for Industrial and Occupational Chemicals |
|
|
621 | (102) |
Index |
|
723 | |